Antitrust Suits Spread Through Fertilizer Industry
Cooley partner Dee Bansal warned that a surge of antitrust lawsuits targeting fertilizer companies appears to be driven by reports of a government investigation. He cautioned that these cases are likely to be lengthy and costly, underscoring the importance of robust antitrust compliance programs. The recent filings act as a stark reminder for firms to reassess their competitive practices and legal safeguards.
Europe’s New Tech-Licensing Rules: Evolution, Not Revolution
On May 1 2026 the EU’s revised Technology Transfer Block Exemption Regulation (TTBER) and accompanying Guidelines took effect, updating the 2014 framework that governed technology‑licensing agreements. The overhaul adds explicit treatment for data licensing, extends the market‑share breach grace period to three...
Trade Court Rejects Section 122 Tariffs, Appeal Pending
The US Court of International Trade ruled in a split decision that the Trump administration’s 10% global tariff imposed under Section 122 of the Trade Act of 1974 is invalid and exceeds statutory authority. The court issued a permanent injunction that...
Cooley Extends Run as #1 Ranked Global, US Advisor to Venture-Backed Companies
Cooley was again named the #1 law firm globally and in the United States for representing companies raising venture capital, according to PitchBook’s Q1 2026 Global League Tables and LSEG’s review. The firm also led in deal count and overall deal...
Mentari Therapeutics Announces Merger with InMed Pharmaceuticals, Concurrent $290 Million Private Placement
Mentari Therapeutics, a biotech focused on migraine prevention, announced a merger with InMed Pharmaceuticals alongside a $290 million private placement. The financing round was led by Fairmount and featured investors such as a16z Bio + Health, Venrock, Wellington Management, and Blackstone...
Cooley Reinforces Leading Privacy Practice for Major Tech Companies
Cooley announced that Meredith Halama and Katie Cramer have joined its global cyber/data/privacy group as partners, bolstering the firm’s ad‑tech privacy practice. Both lawyers come from Perkins Coie, where Halama co‑chaired the privacy and security practice and Cramer built a...
Orphai Therapeutics Sale to Quince Therapeutics
Quince Therapeutics announced the acquisition of Orphai Therapeutics, a clinical‑stage biotech focused on rare pulmonary diseases. The deal brings Orphai’s lead inhaled rapamycin program, LAM‑001, into Quince’s pipeline and is supported by a private placement of up to $187 million. Cooley...
Sedona Conference Publishes Model Jury Instructions on DTSA’s 10th Anniversary
The Sedona Conference’s Trade Secrets Working Group has published the first model jury instructions for federal Defend Trade Secrets Act (DTSA) cases, concluding a three‑year, consensus‑driven drafting effort. The instructions cover trade‑secret definition, misappropriation, and damages, seeking to bring uniformity...
Playground Global Announces $475 Million Fourth Fund
Playground Global announced a $475 million fourth fund aimed at backing the next generation of deep‑technology companies. The new capital follows a $410 million Fund III closed in December 2023, reflecting a sizable increase in investor commitment. Cooley LLP advised the fund formation, continuing...
DoD Targets Foreign Ownership Disclosure in Proposed DFARS Rule
The Department of Defense issued a proposed DFARS rule requiring contractors and subcontractors with contracts exceeding $5 million to disclose foreign ownership, control or influence (FOCI) and beneficial‑owner information before award, and to keep those disclosures current throughout performance. The rule...
908 Devices Inc. Acquires NIRLAB AG
908 Devices Inc., a leader in handheld real‑time chemical analyzers, announced the acquisition of Swiss AI‑driven spectroscopy firm NIRLAB AG. The deal, advised by Cooley LLP on corporate and capital‑markets matters, adds NIR‑based narcotics detection to 908 Devices' portfolio. NIRLAB’s...
CoinDesk Live at Consensus Miami
Cooley partner Brian Klein appeared on CoinDesk Live during the Consensus Miami 2026 conference, providing an update on the high‑profile case of client Roman Storm. He warned crypto founders about mounting legal risks as U.S. federal agencies adopt a more...
FCC Proposes Making Spectrum Available for ‘Weird Space Stuff’
On March 26 the FCC released a Notice of Proposed Rulemaking titled “Spectrum Abundance for Weird Space Stuff,” inviting comments by May 11, 2026. The agency outlines two pathways to free up radio spectrum for emerging space activities: expanding existing...
The SEC’s Semiannual Reporting Proposal: Fare Thee Well Quarterly Reporting?
On May 5, 2026 the SEC proposed a rule change that would let domestic Exchange Act filers elect to file a single semiannual interim report on a new Form 10‑S instead of the traditional three quarterly Form 10‑Q filings. The election is...
Delos Capital and AP Biosciences Launch Collaboration to Create New Biotech Companies
Delos Capital and AP Biosciences have announced a strategic collaboration to launch and incubate new biotechnology companies focused on next‑generation antibodies. Through its Delos Foundry, Delos will lead therapeutic ideation, financing, and strategic development, while APBio supplies its proprietary antibody...